COVID-19 vaccine development depends on identifying potent neutralizing antibodies. Recent research studies suggest that neutralizing antibodies found in the blood of recovered COVID-19 patients decay rapidly and the level of antibody protection may correlate with infection severity. In this webinar brought to you by The Scientist, scientists studying the SARS-CoV-2 immune response will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.
Topics to be covered
- Assessing antibodies to SARS-CoV-2 in the saliva of COVID-19 patients
- Examining immune memory formation and persistence in individuals that recovered from mild COVID-19
Meet the Speakers:
Jennifer Gommerman, PhD
Professor, Department of Immunology
Canada Research Chair in Tissue Specific Immunity
Associate Chair, Graduate Studies, Department of Immunology
University of Toronto
Marion Pepper, PhD
Associate Professor, Department...